Extended-spectrum ␤-lactamase (ESBL)-producing Klebsiella pneumoniae strains are suggested to possess higher pathogenic potential than non-ESBL producers. Microbial adherence to and invasion of host cells are critical steps in the infection process, so we examined the expression of type 1 and 3 fimbrial adhesins by 58 ESBL-producing and 152 nonproducing isolates of K. pneumoniae and their abilities to invade ileocecal and bladder epithelial cells. Mannose-sensitive hemagglutination of guinea pig erythrocytes and mannose-resistant hemagglutination of ox erythrocytes were evaluated to determine the strains' abilities to express type 1 and type 3 fimbriae, respectively. Bacterial adhesion to and invasion of epithelial cells were tested by enzyme-linked immunosorbent assay and imipenem killing assay, respectively. The adherence of ESBL-and non-ESBLproducing strains to epithelial cells did not differ significantly (P > 0.05). In contrast, the proportion of strains capable of invading (>5% relative invasion) ileocecal and bladder epithelial cells was significantly higher among ESBL producers (81%, n ‫؍‬ 47/58, and 27.6%, n ‫؍‬ 16/58, respectively) than among non-ESBL producers (61%, n ‫؍‬ 93/152, and 10%, n ‫؍‬ 15/152, respectively) (P ‫؍‬ 0.0084, odds ratio [OR] ‫؍‬ 2.711, 95% confidence interval [CI] ‫؍‬ 1.302 to 5.643 and P ‫؍‬ 0.0021, OR ‫؍‬ 4.79, 95% CI ‫؍‬ 1.587 to 7.627). The mean invasion by ESBL producers (5.5% ؎ 2.8% and 3.3% ؎ 2.7%, respectively) was significantly higher than that by non-ESBL producers (2.9% ؎ 2.6% and 1.8% ؎ 2%, respectively) (P < 0.0001). Likewise, the proportion of ESBL producers coexpressing both fimbrial adhesins was significantly higher (79.3%; n ‫؍‬ 46/58) than that of non-ESBL producers (61.8%; n ‫؍‬ 94/152) (P ‫؍‬ 0.0214; OR ‫؍‬ 2,365; 95% CI ‫؍‬ 1.157 to 4.834). Upon acquisition of SHV-12-encoding plasmids, two transconjugants switched on to produce type 3 fimbriae while expression of type 1 fimbriae was not affected. The acquisition of an ESBL plasmid appeared to upregulate the phenotypic expression of one or more genes, resulting in greater invasion ability.
Klebsiella pneumoniae is one of the most common pathogens causing nosocomial infections that affect mainly immunocompromised patients with severe underlying diseases. Its frequency ranges from 3% to 17% of all nosocomial infections, placing it among the eight most relevant pathogens in hospitals (15, 16, 19, 20, 27, 48, 51, 53) .
Of particular interest is the dramatic worldwide spread of extended-spectrum ␤-lactamase (ESBL)-producing Klebsiella strains that are resistant to third-generation cephalosporins and that often display cross-resistance to aminoglycosides and quinolones (36, 37, 39, 41) . It is estimated that the proportion of ESBL production among K. pneumoniae strains ranges from 12% in the United States to 33% in Europe, 28% in the Western Pacific, and 52% in Latin America (25) . Because ESBL-producing bacteria are often resistant to a variety of antibiotics, carbapenems have become the drug of choice against ESBL-producing strains (38) .
Infections caused by ESBL producers are associated with severe adverse outcomes (28, 46, 47) . This is related in part to delay in effective therapy and the failure to use an antibiotic active against ESBL-producing K. pneumoniae. However, the high mortality rate observed with infections caused by ESBL producers may also be related to increased virulence of these strains. Indeed, several studies have reported an association between ESBL production and the higher expression of pathogenicity factors in Klebsiella. Significantly, it has been shown that ESBL-producing Klebsiella strains exhibit increased adherence to human epithelial cells, probably due to plasmidencoded production of fimbrial or nonfimbrial adhesins (2, 5, 6, 29) . Most K. pneumoniae strains express two types of fimbrial adhesins (hemagglutinins), one of which is the mannose-sensitive (MS) type 1 while the other is the mannose-resistant (MR) type 3 (26) . Type 1 fimbriae mediate MS hemagglutination (MSHA), are expressed by many enterobacterial species, and play an important role in their pathogenesis (34, 35) . Significantly, type 1 fimbriae of Klebsiella and Escherichia coli have been shown to be important in urinary tract infections (1, 10, 11, 30, 31, 32) . They can facilitate attachment of Klebsiella to a wide range of cells, including those of the urinary and respiratory tracts (12, 30) . Type 3 fimbriae are capable of mediating binding of Klebsiella spp. to various human cells, such as endothelial and epithelial cells of the respiratory and urinary tracts (22, 23, 24, 49, 50, 52) . Furthermore, they were shown to facilitate adherence and biofilm formation on inert surfaces (4). Although K. pneumoniae is considered to be an extracellular pathogen, several studies have revealed the ability of the bacterium to invade and persist in epithelial cells (13, 14, 33, 45) .
Because adherence of the microorganisms to and subsequent invasion of host cells are considered critical steps in the infection process (34), we sought to examine the abilities of a large number of ESBL-producing and non-ESBL-producing strains of K. pneumoniae to express the type 1 and 3 fimbrial adhesins and to adhere to and invade epithelial cell lines. It will be shown that the proportion of strains among the ESBLproducing Klebsiella isolates capable of invading ileocecal and bladder epithelial cells and of expressing the fimbrial adhesins is significantly higher than among non-ESBL-producing isolates.
MATERIALS AND METHODS
Bacterial cells and culture conditions. A total of 58 ESBL-producing and 152 non-ESBL-producing K. pneumoniae strains described elsewhere were employed in the study. The strains were isolated from clinical specimens from hospitalized patients in different European countries, tested for ESBL production, serotyped with respect to O and K antigens, and analyzed for clonality as described previously (42, 43) . Production of ESBLs was detected according to the recommendations of the CLSI (formerly NCCLS) as described previously (43) .
Hemagglutination assays. The expression of type 1 (MSHA) and type 3 (mannose-resistant Klebsiella-like hemagglutination [MR/K-HA]) pili was examined as described previously (40) . Briefly, after four passages (either serial 48-h passages in static brain heart infusion broth for the detection of MSHA or passage in nutrient broth for detection of MR/K-HA), the bacteria were allowed to grow statically for 48 h, at which time they were harvested and washed three times with phosphate-buffered saline. Fifty microliters of bacterial suspension (3 ϫ 10 9 CFU/ml) was mixed on porcelain plates with 50 l erythrocyte suspension (5 ϫ 10 8 /ml). Agglutination was observed after 3 min of gentle shaking at room temperature and after another 10 min at 4°C, and the intensity of the reaction was graded from Ϫ to ϩϩϩ. Positive MSHA of guinea pig erythrocytes or hemagglutination of tanned ox erythrocytes indicated expression of type 1 or type 3 MR/K-HA fimbrial adhesins, respectively, by at least 10% of the bacterialcell population.
Detection of fimbria-encoding genes. The genes coding for type 1 (MSHA) and type 3 (MR/K-HA) pili were detected by colony hybridization using as probes the insert of pGG101 (fimAE SphI; 1.6 kb) and the insert of pFK10 (mrkBC KpnI; 2.8 kb), respectively (17, 18) . For each strain, 1 microliter of overnight culture in Luria-Bertani (LB) broth was spotted onto Hybond-N nylon membranes (Amersham France, Les Ulis, France), placed on solid LB medium, incubated for 6 h at 37°C, and lysed according to the manufacturer's instructions. DNA probes were labeled with [␣-32 P]dATP by using a random-primed DNA-labeling kit (Boehringer Mannheim, Meylan, France). Hybridization was performed with Rapid-hyb buffer (Amersham) as recommended by the manufacturer under high-stringency conditions. In addition, detection of the type 3-encoding gene (mrkD) was performed by PCR as described previously (21) .
Cell lines and culture conditions. The human bladder epithelial cell line T24 and the ileocecal cell line HCT8 were cultivated as described previously (45) . The T24 cells were cultivated in McCoy's 5A medium with 10% fetal bovine serum and the HCT8 cells in RPMI 1640 medium with 1 mM pyruvate, 2 mM glutamine, and 10% fetal calf serum and subcultivated at a ratio of 1:8 twice a week. Human A549 adenocarcinoma cells were cultivated in F-12K medium with 10% (vol/vol) fetal calf serum and 2 mM glutamine as described elsewhere (44) .
Invasion assay. The ability of the bacteria to invade epithelial cells was measured as described previously (45) . The cells were cultured in 24-well cell culture clusters to monolayers of approximately 7 ϫ 10 4 cells/well. Two ϫ 10 6 mid-logphase bacteria were then added to each well (approximately 30 bacteria/epithelial cell). After centrifugation at 200 ϫ g for 5 min, invasion was allowed to occur for 2 h at 37°C in an atmosphere of 94% air-6% CO 2. Before a second 2-h incubation (kill) period under the same conditions but with fresh medium containing 100 g of imipenem/ml, the monolayers were washed once with Earle's balanced salt solution (EBSS). All extracellular, but not internalized, bacteria were killed by the added imipenem during the kill period. The monolayers were then washed twice with EBSS and lysed with 0.1% Triton X-100 before determination of viable counts of the released intracellular bacteria. The invasion ability was expressed as the percentage of the inoculum surviving imipenem treatment. The invasion was classified into two grades: grade I, invasion of Ͻ5% of the inoculum, and grade II, invasion of Ͼ5% of the inoculum. The distribution of the strains' invasion and the mean relative invasion were calculated. Adhesion assay. The adhesion of six strains that harbored the ESBL-encoding plasmid and of their plasmid-cured derivatives (see below) to epithelial cells was tested as described previously (44) . Briefly, 50 l of the bacteria (ca. 10 8 CFU/ ml) was added to wells of flat-bottom microtiter plates containing confluent monolayers of T24, HCT8, or A549 cells. After 30 min at room temperature, the nonadherent bacteria were removed by repeated washing with EBSS, and the cell monolayers were fixed with 2.5% glutaraldehyde in Hanks balanced salt solution for 5 min. The plates were then washed and incubated in blocking buffer overnight at 4°C. The bound bacteria were quantified using anti-Klebsiella serum at 1:1,000 in enzyme-linked immunosorbent assays.
Preparation of plasmid DNA and plasmid curing. To investigate the contribution of the ESBL-encoding plasmid to the ability of the bacteria to produce type 1 and type 3 pili and to adhere to and invade the epithelial cells, five strains harboring the ESBL-encoding plasmid, expressing type 1 and type 3 pili, and positive in the adhesion and invasion assays were subjected to a plasmid-curing procedure as described elsewhere (43) . The plasmid-cured derivatives obtained were tested for ESBL production and for the ability to express the pathogenicity factors as described above.
Transconjugation and its effect on pilus expression. Transconjugation experiments were performed by filter mating (45) using two ESBL-producing K. pneumoniae isolates (isolates 1054 and 1147) as donors and one non-ESBLproducing K. pneumoniae isolate as a recipient strain (KPTA 29).
Transconjugants were selected on LB agar plates containing nalidixic acid (128 g/ml) and ceftriaxone (4 g/ml) and subjected to Vitek-2 susceptibility testing. ESBL production was confirmed as described above. Pulsed-field gel electrophoresis was used to confirm the genetic identity of the transconjugants and the recipient parental strain. The acquisition of ESBL-encoding plasmids was verified by comparative plasmid analysis of the donor and recipient strains. PCR confirmed the presence of the expected ESBL genes. Two confirmed transconjugants, T1147 and T1054, were assayed for the ability to express type 1 and type 3 pili.
To further verify the influence of ESBL-producing plasmids on type 3 fimbrial expression, a real-time reverse transcription (RT)-PCR was conducted. For this purpose, RNA was extracted from 1 ml of a 5-h culture using the NucleoBond NucleoSpin NucleoTrap kit from Machery-Nagel (Düren, Germany) according to the manufacturer's instructions. The real-time RT-PCR step was carried out with the LightCycler RNA Master Sybr green I kit (Roche Diagnostics, Mannheim, Germany) on LightCycler systems (Roche Diagnostics) with primers MrkD 2 F (5Ј-CCACCAACTATTCCCTCGAA-3Ј) and MrkD 2 R (5Ј-ATGG AACCCACATCGACATT-3Ј) (GenBank accession number AY225462). As an internal control, the 16S rRNA gene was amplified with universal primers TM1 (5Ј-ATGACCAGCCACACTGGAAC-3Ј) and TM2 (5Ј-CTTCCTCCCCGCTG AAAGTA-3Ј). A 20-l mixture containing 1 l of RNA and 2 l of primers was prepared and amplified according to the manufacturer's instructions (the RNA preparations were checked for absence of DNA contamination). To compare relative gene expression in the wild-type strain and its transconjugants, the value 2[(CP transconjugant Ϫ CP wild type ) TM Ϫ (CP transconjugant Ϫ CP wild type ) MrkD ] was calculated, where CP is the crossing point. The experiment was performed twice.
Statistical analysis. The significance of differences between groups of isolates was evaluated by Yate's corrected chi-square test. For tables showing values of n of Ͻ5 within a cell, Fisher's exact test was used. The odds ratio (OR) and 95% confidence interval (CI) were determined, and the values were taken as a gauge of association. The significance of differences between the relative invasion levels of the tested bacteria was evaluated by the unpaired t test with Welch correction.
ESBL-producing strains were defined. Sixteen ESBL types were identified, among which SHV-5 was the most common (23%; 12/58 isolates), followed by TEM-3 (15.6%; 9/58 isolates), SHV-4 and SHV-12 (each 10%; 6/58 isolates), and TEM-24 (8.6%; 5/58 isolates). SHV-2, -2A, -36, and -40 and TEM-5, -8, -12, -15, and -16 were detected in one strain each.
Expression of type 1 and type 3 fimbriae. The percentages of strains that did not express either type 1 or type 3 fimbrial adhesin were very low (i.e., 3.5% and 5.2% of ESBL-producing and non-ESBL-producing strains, respectively) ( Table 1) , suggesting that at least one of the adhesins is required for colonization irrespective of the presence of the ESBL plasmid. Non-ESBL-producing strains produced one of the fimbrial adhesins more often than ESBL producers: 50 out of the 152 non-ESBL-producing strains (32.8%) expressed either type 1 or type 3 fimbrial adhesins, and only 10 out of the 58 (17.2%) ESBL producers did so (P ϭ 0.0268; OR ϭ 2.353; 95% CI ϭ 1.099 to 5.036). In contrast, the frequency of ESBL-producing strains coexpressing both type 1 and type 3 fimbrial adhesins was significantly higher than that of the non-ESBL producers (79.3% and 61.8%, respectively) (P ϭ 0.0214; OR ϭ 2,365; 95% CI ϭ 1.157 to 4.834).
The magnitudes of the hemagglutination of guinea pig erythrocytes and of tanned ox erythrocytes did not differ significantly between the ESBL-producing and non-ESBL-producing strains (P Ͼ 0.05) ( Fig. 1 A and B) , suggesting that once the adhesin genes are turned on, the phenotypic expression of the adhesins is not affected by the presence of ESBL plasmids. Colony hybridization revealed the presence of the type 1-encoding genes in all but one strain, and only two did not harbor the type 3-encoding genes.
Adhesion and invasion ability. The adherence rates of ESBL-and non-ESBL-producing strains to ileocecal, bladder, and alveolar epithelial cells did not differ significantly (P Ͼ 0.05) (Fig. 2) . In contrast, the frequency of isolates that efficiently invaded ileocecal epithelial cells (grade II invasion, Ͼ5% of the inoculum) was higher among ESBL producers than among non-ESBL producers (Table 2 ) (81%, 47/58, and 61%, 93/152, respectively; P ϭ 0.0084; OR ϭ 2.711; 95% CI ϭ 1.302 to 5.643). Likewise, 27.7% (n ϭ 16/58) of the ESBL producers invaded the bladder T24 cells efficiently, whereas only 10% (n ϭ 15/152) of the non-ESBL producers did so (P ϭ 0.0021; OR ϭ 3.479; 95% CI ϭ 1.587 to 7.627). The mean percent relative invasion of HCT8 and T24 cells by ESBLproducing strains (5.5% Ϯ 2.8% and 3.3% Ϯ 2.7%) was significantly higher than that of non-ESBL producers (2.9% Ϯ 2.6% and 1.8% Ϯ 2%) (P Ͻ 0.0001) (Fig. 3) . The invasion of the A549 lung epithelial cells by both ESBL and non-ESBL producers did not exceed 1%.
Hemagglutination, adhesion, and invasion abilities of plasmid-cured strains. Five strains were cured of their ESBL plasmids. The lack of an ESBL-producing phenotype in all plasmid-cured derivatives was confirmed using the CLSI guide- . In all cured strains, the MICs to third-generation cephalosporins, e.g., cefotaxime, ceftriaxone, and ceftazidime, were Ͻ2 g/ml. There was no difference between the five plasmid-cured derivatives and their parental strains in the abilities of the strains to express type 1 and type 3 fimbriae and to adhere to and invade tissue culture cell lines (Fig. 4) .
Hemagglutination of transconjugants.
The parental recipient strain KPTA 29 expressed type 1 pili (e.g., it induced MSHA of guinea pig erythrocytes), but not type 3 fimbriae (e.g., it did not induce MR hemagglutination of ox erythrocytes). Two transconjugant, T1147 and T1054, of this strain that acquired the ESBL plasmid were obtained, and both switched on to express type 3 fimbriae, as shown in a hemagglutination assay of tanned ox erythrocytes. Specific PCR indicated that both the wild-type strain KPTA 29 and its two transconjugants, T1147 and T1054, harbored the type 3-encoding genes (data not shown). Differences in type 3 fimbrial expression were further studied in the parental strain and both transconjugants by real-time RT-PCR. A 226-bp fragment of the mrkD gene was targeted. The comparative CP values between the parental strain and the transconjugants T1054 and T1147 were, respectively, 3,702 and 5,595 (average CP values), indicating that type 3 fimbrial expression was upregulated in both transconjugants, consistent with the hemagglutination results.
DISCUSSION
A number of findings support the notion that infections caused by ESBL-producing Klebsiella strains are associated with severe adverse outcomes by virtue of the greater abilities of these strains to express pathogenicity factors. These findings include (i) the fact that ESBL plasmids mediate the adhesive properties of Klebsiella (2, 5, 6, 29) , (ii) the fact that ESBL producers exhibit increased ability to resist the bactericidal activity of serum (43) and to evade opsonin-mediated phagocytosis and killing by polymorphonuclear granulocytes (42) , and (iii) demonstration in the present study that the proportion of ESBL-producing strains that simultaneously express MS and MR pili and that are capable of invading ileocecal and bladder epithelial cells is significantly higher among ESBL producers than non-ESBL producers.
It has been shown that invasion of nonphagocytic cells by the bacteria requires the coexpression of numerous components to involve signal transduction via receptors different from those required for the adhesion process (3, 7, 8, 9) . It can be speculated that the greater invasive abilities of the ESBL-producing strains might be due to the higher frequency of strains that coexpressed both the type 1 and type 3 fimbriae, supporting the notion that both fimbrial types are important virulence factors by virtue of their ability to adhere to epithelial cells and extracellular matrix. Indeed, the percentages of Klebsiella isolates from different clinical sources expressing both adhesins were found to be significantly higher than that of strains isolated from sewage (40) . Likewise, in the present study, most of the clinical isolates produced at least one adhesin, and many produced both adhesins. Because the assessment of adhesion by hemagglutination is qualitative, we cannot speculate whether the invasion process requires expression of both type 1 and type 3 fimbriae or if only one fimbrial adhesin expressed in higher quantity per cell suffices. Furthermore, using the impenem killing assay to distinguish between intracellular and extracellular bound bacteria assumes that impenem neither diffuses into the cells nor acts to inhibit bacteria exposed to the antibiotic before entry into the cells. These assumptions require further validation.
Interestingly, the elimination of the plasmid that encoded ESBL production did not influence the ability of strains to adhere to or invade the epithelial cells, indicating that the invasion potential of Klebsiella is chromosomal rather than plasmid mediated, contradicting previous reports indicating an R plasmid-restricted increase in adhesive properties (2, 5, 6, 29). Alternatively, the adhesion/invasion of the strains in the studies cited above might be mediated by adhesins that differ from those expressed by the strains in the present study. The expression of fimbrial adhesins is under tight phase variation control involving the switching of fim gene translation from off to on and vice versa at a defined frequency (34) . The presence of the ESBL plasmid could increase the conversion frequency of type 3 fimbrial-gene translation from off to on without changing the phenotypic expression of type 1 fimbriaencoding genes. Such increased and specific conversion may result in a significantly higher proportion of strains among ESBL producers that phenotypically express both type 1 and type 3 fimbrial adhesins and, as a consequence, better invade epithelial cells. It is tempting to speculate that upon acquisition of the ESBL plasmid a number of chromosomal-gene rearrangements occur, involving the turning on of some of them. Indeed, most strains were shown to harbor the genes coding for both fimbrial types, but only a portion of them phenotypically expressed one or both adhesion phenotypes.
Taken together, the data suggest that the increase in mortality and severity of infections caused by ESBL producers is not due to the appearance of new virulence factors but rather to an increase in the abilities of the ESBL strains to simultaneously express several virulence factors. This notion is supported by our findings showing that acquisition of the ESBL plasmid rendered the transconjugants phenotypically capable of expressing fimbrial genes that were not expressed in the parent recipient strain. Thus, while the proportion of strains simultaneously exhibiting several virulence factors and therefore causing severe infections was relatively small in the pre-ESBL era, it has significantly increased in the post-ESBL era. Unraveling the complex intracellular events that promote the expression of virulence factors upon acquisition of the ESBL plasmid may provide an informed approach for better management of nosocomial infections caused by ESBL producers. 
